MMPs in BAL from patients with scleroderma fibrosing alveolitis Source: Eur Respir J 2006; 28: Suppl. 50, 564s Year: 2006
Sputum eosinophilia in cryptogenic fibrosing alveolitis Source: Eur Respir J 2003; 22: Suppl. 45, 227s Year: 2003
Induced sputum as a surrogate for BAL for the measurement of the monocyte/macrophage chemokines MCP-1 and MIP-1α in scleroderma fibrosing alveolitis Source: Eur Respir J 2006; 28: Suppl. 50, 309s Year: 2006
Biomarkers of fibroproliferative healing in fibrosing idiopathic interstitial pneumonias Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013
Macrophage derived inflammatory mediators and thoracic HRCT scoring in scleroderma fibrosing alveolitis Source: Eur Respir J 2002; 20: Suppl. 38, 227s Year: 2002
Induced sputum neutrophilia and increased neurotrophin levels in patients with cryptogenic fibrosing alveolitis Source: Eur Respir J 2002; 20: Suppl. 38, 173s Year: 2002
Cytokine gene polymorphisms in fibrosing alveolitis in rheumatoid arthritis and idiopathic pulmonary fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 1s Year: 2001
The study of C5a complement component in patients with idiopathic pulmonary fibrosis, toxic fibrosing alveolitis and extrinsic allergic alveolitis Source: Eur Respir J 2001; 18: Suppl. 33, 108s Year: 2001
Cytokine regulation in idiopathic fibrosing alveolitis (IFA) and lung sarcoidosis: clinicomorphological study Source: Eur Respir J 2001; 18: Suppl. 33, 107s Year: 2001
Exhaled 8-isoprostane as a noninvasive marker of oxidative stress in patients with cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis Source: Eur Respir J 2001; 18: Suppl. 33, 408s Year: 2001
Role of Wnt-1, Wnt-3 and MMP-7 in fibrotic response in extrinsic allergic alveolitis and idiopathic pulmonary fibrosis Source: International Congress 2015 – Interstitial lung diseases II Year: 2015
Cryptogenic fibrosing alveolitis/idiopathic pulmonary fibrosis Source: Eur Respir J 2001; 18: 43S-55S Year: 2001
Lung cancer in patients with cryptogenic fibrosing alveolitis Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008
Clinical significance of different cytokines expression in lung tissue in idiopathic fibrosing alveolitis (IFA) and lung sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 313s Year: 2002
Plasma fibronectin as the criterion of idiopathic fibrosing alveolitis severity Source: International Congress 2017 – IPF: from the bench to the bedside Year: 2017
Concentrations of IL4Ra and TNFa in bronchoalveolar lavage fluid can distinguish hypersensitivity pneumonitis from other fibrosing interstitial lung diseases Source: International Congress 2017 – Lung fibrosis: basic science Year: 2017
Clinical significance of morphological indexes of inflammation and sclerosis in idiopathic fibrosing alveolitis (IFA) and lung sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 107s Year: 2002
Renin is an angiotensin-independent profibrotic mediator: role in pulmonary fibrosis Source: Eur Respir J 2011; 39: 141-148 Year: 2012
Renin is an angiotensin-independent profibrotic mediator: role in pulmonary fibrosis Source: Eur Respir J 2012; 39: 141-148 Year: 2012
Progressive fibrosing ILDs Source: Virtual Congress 2021 – Interstitial lung diseases Year: 2021